Order Article Reprints

Zecca E, Rizzi M, Tonello S, Matino E, Costanzo M, Rizzi E, Casciaro GF, Manfredi GF, Acquaviva A, Gagliardi I, et al. Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort. Viruses. 2022; 14(8):1766. https://doi.org/10.3390/v14081766

Zecca, Erika, Manuela Rizzi, Stelvio Tonello, Erica Matino, Martina Costanzo, Eleonora Rizzi, Giuseppe Francesco Casciaro, Giulia Francesca Manfredi, Antonio Acquaviva, Ileana Gagliardi, and et al. 2022. "Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort" Viruses 14, no. 8: 1766. https://doi.org/10.3390/v14081766

Zecca, E., Rizzi, M., Tonello, S., Matino, E., Costanzo, M., Rizzi, E., Casciaro, G. F., Manfredi, G. F., Acquaviva, A., Gagliardi, I., Calzaducca, E., Mallela, V. R., D’Onghia, D., Minisini, R., Bellan, M., Castello, L. M., Gavelli, F., Avanzi, G. C., Patrucco, F., ... Sainaghi, P. P. (2022). Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort. Viruses, 14(8), 1766. https://doi.org/10.3390/v14081766